Pre-treatment tumour oxygen measurements for Prostate Cancer

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Prostate CancerPre-treatment tumour oxygen measurements - Procedure
Eligibility
18 - 80
Male
What conditions do you have?
Select

Study Summary

This trial is testing whether low levels of oxygen in the tumor (hypoxia) play a role in prostate cancer.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: after follow up is completed

after follow is completed
To determine the relationship between pre-treatment tumor oxygen levels and the subsequent development of metastases and androgen-resistant prostate cancer.
after follow up is completed
To determine the relationship between pre-treatment tumor oxygen levels and mutations of the p53 gene, and the impact of this interaction on patient outcome.
To determine whether androgen ablation overcomes any adverse effect of hypoxia on outcome.
after follow-up is completed
To determine the relationship between pre-treatment prostate cancer oxygen levels and long-term disease control following treatment with radiotherapy, and the independent prognostic effect of oxygen measurements.
To evaluate oxygen levels in clinically localized prostate cancer prior to treatment.

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

1 Treatment Group

hypoxia and RT in prostate cancer
1 of 1

Experimental Treatment

195 Total Participants · 1 Treatment Group

Primary Treatment: Pre-treatment tumour oxygen measurements · No Placebo Group · Phase 2

hypoxia and RT in prostate cancer
Procedure
Experimental Group · 1 Intervention: Pre-treatment tumour oxygen measurements · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: after follow up is completed

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,382 Previous Clinical Trials
473,280 Total Patients Enrolled
63 Trials studying Prostate Cancer
15,372 Patients Enrolled for Prostate Cancer
Princess Margaret Hospital, CanadaOTHER
114 Previous Clinical Trials
29,893 Total Patients Enrolled
8 Trials studying Prostate Cancer
1,516 Patients Enrolled for Prostate Cancer
U.S. Army Medical Research and Development CommandFED
278 Previous Clinical Trials
244,538 Total Patients Enrolled
Michael Milosevic, MDPrincipal InvestigatorPrincess Margaret Hospital, Canada
10 Previous Clinical Trials
953 Total Patients Enrolled

Eligibility Criteria

Age 18 - 80 · Male Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have not received hormonal or cytotoxic anti-cancer therapy prior to study entry.
You can understand the English language.